STOCK TITAN

ReShape Lifesciences Inc. (RSLS) Net Income by Year

RSLS

ReShape Lifesciences Inc. reported a net loss of $10.3M in fiscal year 2025. This represents a decrease of 609.0% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters ReShape Lifesciences Inc. has filed alongside them.

FY2025 annual
Net Income -$10.3M
YoY -609.0%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RSLS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Net Income-$10.3M-609.0%-$1.4M+87.3%-$11.4M+75.4%-$46.2M+26.8%-$63.1M-191.9%-$21.6M+8.6%-$23.7M+36.7%-$37.4M-7.5%-$34.8M-69.9%-$20.5M-31.6%-$15.6M-57.3%-$9.9M

RSLS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'25Q2'2510-QQ1'2510-QQ4'2410-KQ3'24Q2'2410-QQ1'24Q4'23Q3'23Q2'23
Net Income-$963K-227.5%N/A-$8.4M-1439.7%-$2.6M-64.9%-$294K+86.6%N/A-$548K+84.5%-$1.6M+54.3%-$2.2M+17.6%-$1.7M+89.7%-$3.5M+71.0%-$3.5M+63.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More ReShape Lifesciences Inc. financials

Frequently Asked Questions

What was ReShape Lifesciences Inc.'s net income in fiscal year 2025?

ReShape Lifesciences Inc. reported a net loss of $10.3M in fiscal year 2025.

How fast is ReShape Lifesciences Inc.'s net income growing?

ReShape Lifesciences Inc. (RSLS) net income fell by 609.0% year over year, from -$1.4M to -$10.3M in fiscal year 2025.

How has ReShape Lifesciences Inc.'s net income changed over the years?

Across the 12 fiscal years this page covers, ReShape Lifesciences Inc. (RSLS) net income went from -$9.9M in fiscal year 2014 to -$10.3M in fiscal year 2025.

ReShape Lifesciences Inc. (RSLS) reported -$963K in net income in Q1 2026. This represents a decrease of 227.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ReShape Lifesciences Inc. (RSLS) reported on that line in every period on record.